Журналов:     Статей:        

Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2016; 15: 32-39

Использование метода пространственной генерации тромбина для оценки прокоагулянтной активности тромбоцитов после трансфузии тромбоконцентрата у детей

Кольцова Екатерина Михайловна, Баландина Анна Николаевна, Демина Ирина Андреевна, Радыгина Светлана Анатольевна, Атауллаханов Фазоил Инноятович, Балашов Дмитрий Николаевич, Пантелеев Михаил Александрович

https://doi.org/10.24287/1726-1708-2016-15-2-32-39

Аннотация

Оценка эффективности трансфузии тромбоконцентрата после трансплантации гемопоэтических стволовых клеток основывается на подсчете количества тромбоцитов и не учитывает их функциональную активность. В работе проведено интегральное исследование состояния гемостаза у 10 детей (возраст от 3 до 16 лет, медиана 11 лет) до и после трансфузии концентрата тромбоцитов с использованием тестов оценки функциональной активности тромбоцитов и генерации тромбина в пространстве (тромбодинамика-40). Через 2 ч после трансфузии тромбоконцентрата количество тромбоцитов увеличилось с 8,0 ± 6,6 до 52,3 ± 25,2 х 109/л. Секреция плотных гранул (1,37 ± 0,48, норма 3,52 ± 1,14 у.е.) и а-гранул (5969 ± 2366, норма 11787 ± 4639 у.е.), активированного (385 ± 167, норма 1279 ± 682 у.е.) и неактивированного гликопротеина IIb/IIIa (3179 ± 1609, норма 5557 ± 2017 у.е.) до трансфузии были снижены по сравнению с показателями здоровых добровольцев и не изменялись после трансфузии. Характерная для здоровых добровольцев «волна тромбина» в исследовании тромбодинамика-40 не формировалась в образцах пациентов как до, так и после трансфузии. После переливания тромбоконцентрата наблюдалось увеличение скорости роста сгустка с 25 ± 8 до 32 ± 4 мкм/мин (p < 0,005) и продукта реакции тромбина с 124 ± 49 до 209 ± 38 мкM*мм (p < 0,001). Увеличение количества тромбина свидетельствует об улучшении свертывания крови после трансфузии тромбоконцентрата, однако показатели функциональной активности тромбоцитов и тромбодинамики-40 не достигают нормальных значений.
Список литературы

1. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al.; Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010 Apr 28;303(16):1617-24. doi: 10.1001/jama.2010.491.

2. Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. 2015 Nov 18;(11):CD010983. doi: 10.1002/14651858.CD010983.pub2.

3. Raj K, Pagliuca A, Bradstock K, Noriega V, Potter V, Streetly M, et al. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning. Biol Blood Marrow Transplant. 2014 Jun;20(6):890-5. doi: 10.1016/j.bbmt.2014.03.003. Epub 2014 Mar 18.

4. Klein O, Chen A, Robey N, Symons H. Alternative donor hematopoietic stem cell transplantation with post-transplant cyclophosphamide for non-malignant disorders. Pediatr Blood Cancer. 2016. doi: 10.1016/j.bbmt.2016.02.001.

5. Ziegler B, Solomon C, Cadamuro J, Jones N. Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy. Clin Appl Thromb Hemost. 2015; 21(6):558-64.

6. Балашов ДН, Трахтман ПЕ. Особенности проведения трансфузионной терапии у пациентов после трансплантации гемопоэтических стволовых клеток. Онкогематология. 2013;8(3):42-7.

7. Nevo S, Enger C, Hartley E, Borinsky ME, Swan V, Fuller AK, et al. Acute bleeding and thrombocytopenia after bone marrow transplantation. Bone Marrow Transplant. 2001 Jan;27(1):65-72.

8. Chaturvedi S, Neff A, Nagler A, Savani U, Mohty M, Savani BN. Venous thromboembolism in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2016 Apr;51(4):473-8. doi: 10.1038/bmt.2015.308. Epub 2015 Dec 21.

9. Pihusch R, Salat C, Schmidt E, Göhring P, Pihusch M, Hiller E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 2002 Nov 15;74(9):1303-9.

10. Gracheva MA, Urnova ES, Sinauridze EI, Tarandovskiy ID, Orel EB, Poletaev AV, et al. Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma. Leuk Lymphoma. 2015;56(12):3418-25. doi: 10.3109/10428194.2015.1041385. Epub 2015 Jun 18.

11. Seregina EA, Nikulina OF, Tsvetaeva NV, Rodionova MN, Gribkova IV, Orel EB, et al. Laboratory tests for coagulation system monitoring in a patient with ß-thalassemia. Int J Hematol. 2014;99(5):588-96. doi: 10.1007/s12185-014-1559-1. Epub 2014 Mar 9.

12. Серёгина ЕА, Кумскова МА, Грачева МА и др. Материалы VII Всероссийской конференции по клинической гемостазиологии и гемореологии в сердечно-сосудистой хирургии. 2015.

13. Dashkevich NM, Ovanesov MV, Balandina AN, Karamzin SS, Shestakov PI, Soshitova NP, et al. Thrombin activity propagates in space during blood coagulation as an excitation wave. Biophys J. 2012 Nov 21;103(10):2233-40. doi: 10.1016/j.bpj.2012.10.011. Epub 2012 Nov 20.

14. Кольцова Е, Купраш А, Демина И и др. Материалы V съезда биофизиков России. 2015.

15. Balandina A, Koltsova E, Budkova V, et al. Abstracts of the 62ND annual meeting of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. 2016.

16. Ignjatovic V, Pelkmans L, Kelchtermans H, Al Dieri R, Hemker C, Kremers R, et al. Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults. Thromb Res. 2015 Dec;136(6):1303-9. doi: 10.1016/j.thromres.2015.10.034. Epub 2015 Oct 26.

17. Мазуров АВ. Физиология и патология тромбоцитов. М.: ГЭОТАР-Медиа, 2011.

Pediatric Hematology/Oncology and Immunopathology. 2016; 15: 32-39

The use of a spatial thrombin generation method for assessment of platelet procoagulant activity after platelet concentrate transfusion in children

Kol'tsova Ekaterina M., Balandina Junior Anna, Demina Irina A., Radygina Svetlana A., Ataullakhanov Fazoil I., Balashov Dmitrii N., Panteleev Mikhail A.

https://doi.org/10.24287/1726-1708-2016-15-2-32-39

Abstract

Assessment of the effectiveness of platelet concentrate transfusion after hematopoietic stem cell transplantation is based on calculation of the amount of platelets and does not take into account their functional activity. The article offers an integral study of the state of hemostasis in 10 children (aged 3 to 16 years, median 11 years) before and after platelet concentrate transfusion with the use of tests for assessment of platelet functional activity and thrombin generation in space (thrombodynamics-4D). Two hours after platelet concentrate transfusion the amount of platelet increased from 8.0 ± 6.6 to 52.3 ± 25.2 X 109/L. Secretion of platelet dense granules (1.37 ± 0.48, norm 3.52 ± 1.14 units) and a-granules (5969 ± 2366, norm 11787 ± 4639 units), activated (385 ± 167, norm 1279 ± 682 units) and non-activated glycoprotein IIb/IIIa (3179 ± 1609, norm 5557 ± 2017 units) before transfusion was lower as compared with values of healthy volunteers and did not change after transfusion. A characteristic for healthy volunteers «thrombin wave» in studying thrombodynamics-4D was not formed in samples of patients both before and after transfusion. After platelet concentrate transfusion, an increase of the clot growth rate from 25 ± 8 to 32 ± 4 pm/min (p < 0.005) and thrombin reaction product from 124 ± 49 to 209 ± 38 pM*mm was observed (p < 0.001). The increased amounts of thrombin are indicative of improvement of blood coagulation after platelet concentrate transfusion, but parameters of platelet functional activity and thrombodynamics-4D do not reach normal values.
References

1. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al.; Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010 Apr 28;303(16):1617-24. doi: 10.1001/jama.2010.491.

2. Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. 2015 Nov 18;(11):CD010983. doi: 10.1002/14651858.CD010983.pub2.

3. Raj K, Pagliuca A, Bradstock K, Noriega V, Potter V, Streetly M, et al. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning. Biol Blood Marrow Transplant. 2014 Jun;20(6):890-5. doi: 10.1016/j.bbmt.2014.03.003. Epub 2014 Mar 18.

4. Klein O, Chen A, Robey N, Symons H. Alternative donor hematopoietic stem cell transplantation with post-transplant cyclophosphamide for non-malignant disorders. Pediatr Blood Cancer. 2016. doi: 10.1016/j.bbmt.2016.02.001.

5. Ziegler B, Solomon C, Cadamuro J, Jones N. Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy. Clin Appl Thromb Hemost. 2015; 21(6):558-64.

6. Balashov DN, Trakhtman PE. Osobennosti provedeniya transfuzionnoi terapii u patsientov posle transplantatsii gemopoeticheskikh stvolovykh kletok. Onkogematologiya. 2013;8(3):42-7.

7. Nevo S, Enger C, Hartley E, Borinsky ME, Swan V, Fuller AK, et al. Acute bleeding and thrombocytopenia after bone marrow transplantation. Bone Marrow Transplant. 2001 Jan;27(1):65-72.

8. Chaturvedi S, Neff A, Nagler A, Savani U, Mohty M, Savani BN. Venous thromboembolism in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2016 Apr;51(4):473-8. doi: 10.1038/bmt.2015.308. Epub 2015 Dec 21.

9. Pihusch R, Salat C, Schmidt E, Göhring P, Pihusch M, Hiller E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 2002 Nov 15;74(9):1303-9.

10. Gracheva MA, Urnova ES, Sinauridze EI, Tarandovskiy ID, Orel EB, Poletaev AV, et al. Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma. Leuk Lymphoma. 2015;56(12):3418-25. doi: 10.3109/10428194.2015.1041385. Epub 2015 Jun 18.

11. Seregina EA, Nikulina OF, Tsvetaeva NV, Rodionova MN, Gribkova IV, Orel EB, et al. Laboratory tests for coagulation system monitoring in a patient with ß-thalassemia. Int J Hematol. 2014;99(5):588-96. doi: 10.1007/s12185-014-1559-1. Epub 2014 Mar 9.

12. Seregina EA, Kumskova MA, Gracheva MA i dr. Materialy VII Vserossiiskoi konferentsii po klinicheskoi gemostaziologii i gemoreologii v serdechno-sosudistoi khirurgii. 2015.

13. Dashkevich NM, Ovanesov MV, Balandina AN, Karamzin SS, Shestakov PI, Soshitova NP, et al. Thrombin activity propagates in space during blood coagulation as an excitation wave. Biophys J. 2012 Nov 21;103(10):2233-40. doi: 10.1016/j.bpj.2012.10.011. Epub 2012 Nov 20.

14. Kol'tsova E, Kuprash A, Demina I i dr. Materialy V s\"ezda biofizikov Rossii. 2015.

15. Balandina A, Koltsova E, Budkova V, et al. Abstracts of the 62ND annual meeting of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. 2016.

16. Ignjatovic V, Pelkmans L, Kelchtermans H, Al Dieri R, Hemker C, Kremers R, et al. Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults. Thromb Res. 2015 Dec;136(6):1303-9. doi: 10.1016/j.thromres.2015.10.034. Epub 2015 Oct 26.

17. Mazurov AV. Fiziologiya i patologiya trombotsitov. M.: GEOTAR-Media, 2011.